ZIOP - ZIOPHARM Oncology's (ZIOP) CEO Heidi Hagen on Q2 2021 Results - Earnings Call Transcript

ZIOPHARM Oncology, Inc. (ZIOP) Q2 2021 Earnings Conference Call August 9, 2021 4:30 PM ET Company Participants Adam Levy – Executive Vice President-Corporate Development and Investor Relations Heidi Hagen – Interim Chief Executive Officer Raffaele Baffa – Chief Medical Officer Ellee de Groot – Executive Vice President and General Manager-Cell Therapy Conference Call Participants Presentation Operator Greetings. Welcome to the Ziopharm Oncology, Inc. Second Quarter 2021 Corporate Update. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note this conference is being recorded. I will now turn the conference over to your host, Adam Levy, Executive Vice President of Corporate Development and Investor Relations. Thank you. You may begin. Adam Levy Thank you, operator. Good afternoon, and welcome to the Ziopharm Oncology conference call and webcast to review our updates for the second quarter ended June 30, 2021.

For further details see:

ZIOPHARM Oncology's (ZIOP) CEO Heidi Hagen on Q2 2021 Results - Earnings Call Transcript